CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-29 | Malley Thomas Director | Grant or award · Share Option | +30,000 | 30,000 | ||
| 2022-06-29 | Malley Thomas Director | Grant or award · Restricted Share Units | +5,000 | 5,000 | ||
| 2022-06-29 | Levy Richard S Director | Grant or award · Share Option | +30,000 | 30,000 | ||
| 2022-06-29 | Levy Richard S Director | Grant or award · Restricted Share Units | +5,000 | 5,000 | ||
| 2022-06-29 | Popovits Kimberly J Director | Grant or award · Share Option | +30,000 | 30,000 | ||
| 2022-06-29 | Popovits Kimberly J Director | Grant or award · Restricted Share Units | +5,000 | 5,000 | ||
| 2022-06-29 | Cole G Bradley Director | Grant or award · Share Option | +30,000 | 30,000 | ||
| 2022-06-29 | Cole G Bradley Director | Grant or award · Restricted Share Units | +5,000 | 5,000 | ||
| 2022-06-29 | BAKER BROS. ADVISORS LP Director | Grant or award | +10,000 | 108,980 | ||
| 2022-06-29 | BAKER BROS. ADVISORS LP Director | Grant or award | +10,000 | 2,710,597 | ||
| 2022-06-29 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Share Option (right to buy) | +60,000 | 60,000 | ||
| 2022-04-26 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise | +991 | 6,639 | ||
| 2022-04-26 | Ragosa Mark CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −282 | $9.99 | $3K | 6,357 |
| 2022-04-26 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Restricted Share Unit | −991 | 2,971 | ||
| 2022-04-07 | Paolini John F. CHIEF MEDICAL OFFICER | Grant or award · Share Option | +59,930 | 59,930 | ||
| 2022-04-07 | Paolini John F. CHIEF MEDICAL OFFICER | Grant or award · Restricted Share Unit | +9,990 | 9,990 | ||
| 2022-04-07 | Patel Sanj K CHAIRMAN & CEO | Grant or award · Share Option | +239,795 | 239,795 | ||
| 2022-04-07 | Patel Sanj K CHAIRMAN & CEO | Grant or award · Restricted Share Unit | +39,967 | 39,967 | ||
| 2022-04-07 | Moat Ross CHIEF COMMERCIAL OFFICER | Grant or award · Share Option | +59,460 | 59,460 | ||
| 2022-04-07 | Moat Ross CHIEF COMMERCIAL OFFICER | Grant or award · Restricted Share Unit | +9,908 | 9,908 |
Page 67 of 74 · 1,467 trades